Jan 29, 2025 · KKR to become 12% common shareholder in Henry Schein; Henry Schein and KKR to collaborate on range of value creation opportunities; Two KKR representatives with deep sector experience to join the Henry Schein Board as independent directors; Separately, Robert J. Hombach, who brings extensive financial and strategic experience in health care ...

Jan 29, 2025 · Kirkland & Ellis advised global investment firm KKR in its strategic investment in Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners. KKR has agreed to acquire an additional $250 million of common stock in a primary issuance from Henry Schein.

MELVILLE, N.Y., January 29, 2025--Henry Schein announces strategic investment by KKR, board changes, and provides preliminary unaudited financial results and 2025 financial guidance.

Jan 30, 2025 · KKR is excited to support Henry Schein in its mission of enabling dental and medical practitioners, and believe the Company has tremendous growth potential. We look forward to working with the management team on strategic and operational initiatives to drive value for all of Henry Schein’s stakeholders,” said Mr. Lin.

Jan 29, 2025 · MELVILLE, N.Y. -- (BUSINESS WIRE)-- Henry Schein, Inc. (Nasdaq: HSIC) (“Henry Schein” or the “Company”), the world’s largest provider of health care solutions to office-based dental and...

Jan 29, 2025 · KKR will become the largest non-index fund shareholder of Henry Schein with a 12% stake. Under the agreement, Max Lin and William Daniel will join Henry Schein's board as independent directors.

Jan 29, 2025 · As a result, KKR will become the largest non-index fund shareholder in the Company with a 12% position, demonstrating the firm’s confidence in Henry Schein, its management team, and its BOLD+1 ...

Jan 29, 2025 · KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s largest distributor of medical products to office-based dentists and doctors.

Jan 29, 2025 · KKR to invest $250M in Henry Schein, increasing stake to 12%, with an option to reach 14.9%. Henry Schein raises share buyback program by $500M and expects moderate revenue and EPS growth in 2025.

The private-equity firm KKR KKR-8.53% decrease; red down pointing triangle has taken a big stake in the medical- and dental-supply company Henry Schein HSIC 1.27% increase; green up pointing ...